Literatura científica selecionada sobre o tema "Interleukin-6"

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Interleukin-6".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Artigos de revistas sobre o assunto "Interleukin-6"

1

&NA;. "Interleukin-3/interleukin-6." Reactions Weekly &NA;, no. 550 (1995): 11. http://dx.doi.org/10.2165/00128415-199505500-00035.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

&NA;. "Interleukin-6." Reactions Weekly &NA;, no. 570 (1995): 9. http://dx.doi.org/10.2165/00128415-199505700-00023.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Lotz, Martin. "Interleukin-6." Cancer Investigation 11, no. 6 (1993): 732–42. http://dx.doi.org/10.3109/07357909309046948.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

&NA;. "Interleukin 6." Inpharma Weekly &NA;, no. 877 (1993): 2. http://dx.doi.org/10.2165/00128413-199308770-00001.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

&NA;. "Interleukin 6." Reactions Weekly &NA;, no. 505 (1994): 8. http://dx.doi.org/10.2165/00128415-199405050-00037.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

&NA;. "Interleukin 6." Reactions Weekly &NA;, no. 531 (1994): 8. http://dx.doi.org/10.2165/00128415-199405310-00027.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Song, Mingchen, and John A. Kellum. "Interleukin-6." Critical Care Medicine 33, Suppl (2005): S463—S465. http://dx.doi.org/10.1097/01.ccm.0000186784.62662.a1.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

CASTELL, JOSé V., TILO ANDUS, DIETER KUNZ, and PETER C. HEINRICH. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 87–101. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24001.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

LEE, FRANK, CHOY-PIK CHIU, JANUSZ WIDEMAN, et al. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 215–29. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24015.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

CLARK, STEVEN C. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 438–43. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24036.x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Teses / dissertações sobre o assunto "Interleukin-6"

1

Schebesta, Kathrin [Verfasser]. "Das Endothel sezerniert Interleukin-6 (IL-6) und stimuliert die adrenale Interleukin-6 und Aldosteronsynthese über einen Interleukin-6 unabhängigen Mechanismus / Kathrin Schebesta." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2015. http://d-nb.info/1079652612/34.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

OBAFEMI, TOLULOPE FESAYO. "THE EFFECTS OF INTERLEUKIN 6 AND INTERLEUKIN 10 ON FRAILTY IN C57BL/6 MICE." Thesis, The University of Arizona, 2016. http://hdl.handle.net/10150/613394.

Texto completo da fonte
Resumo:
Studies have shown that pro-inflammatory IL-6 and anti-inflammatory IL-10 interleukins may correlate to frailty and aging. This frailty can be defined in the context of clinical symptoms which include sarcopenia and osteoporosis, decreased activity level; or in the context of increased susceptibility to adverse health outcomes from a deficient immune system. In this experiment we tested a cohort of conditionally regulated IL-6 and IL-10 mice with controls (IL-6tg+.rtTA(r/r) (n=8), IL-10(-/-). IL-10tg+ rtTA(r/r) (n=10) and rtTA(r/r) (n=5)) under frailty assessments and immunological cell analys
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Terry, Catherine. "Genetic control of Interleukin-6 gene." Thesis, University of Oxford, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.342452.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Höschen-Lihs, Jutta. "Interleukin-6- und Interleukin-2-Rezeptor als Aktivitätsmarker bei infektiöser Endokarditis." [S.l.] : [s.n.], 2005. http://archiv.ub.uni-marburg.de/diss/z2005/0327/.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Siegmund, Annette. "Interleukin-11 - analog zu Interleukin-6 - ein direkter Modulator der Nebennierenrinde." Diss., lmu, 2008. http://nbn-resolving.de/urn:nbn:de:bvb:19-83542.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Desallais, Lucille. "Immunisation active à base de peptides, dérivés de l’IL-6 et de l’IL-1β, dans les maladies inflammatoires chroniques". Thesis, Paris, CNAM, 2013. http://www.theses.fr/2013CNAM0867.

Texto completo da fonte
Resumo:
Les anticorps monoclonaux anti-cytokine ont constitué une révolution dans le traitement des maladies inflammatoires chroniques, mais leur utilisation présente des inconvénients (non réponse, résistance, effets secondaires, coûts élevés).Notre équipe développe une stratégie alternative originale, l’immunisation active à base de peptides de cytokines. Elle a pour but de faire synthétiser, par l’organisme même du patient, des anticorps neutralisant les effets pathogènes dus à l’excès de cytokines.Durant ma thèse, j’ai montré que l’immunisation active contre un peptide dérivé de l’IL-6 murine est
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Walter, Claudia. "Bestimmung der Zytokine Interleukin-1ra, Interleukin-6, Interleukin-10 und Interleukin-12 im Vaginalsekret bei Frauen mit Bakterieller Vaginose." Diss., lmu, 2004. http://nbn-resolving.de/urn:nbn:de:bvb:19-28461.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Slawik, Helen Christina. "Kontinuierliche Überexpression von Interleukin-6 im Zentralnervensystem lokale Applikation des Designerzytokins Hyper-Interleukin-6 im adulten Organismus der Ratte und Auswirkungen von exzitatorischen Neurotoxinen im Interleukin-6-transgenen Mausmodell /." [S.l.] : [s.n.], 2003. http://www.freidok.uni-freiburg.de/volltexte/842.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Gopinathan, Ganga. "The effects of interleukin-6 on angiogenesis." Thesis, Queen Mary, University of London, 2014. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8186.

Texto completo da fonte
Resumo:
Elevated levels of the inflammatory cytokine interleukin-6, IL-6, have been linked with poor prognosis in ovarian cancer patients by influencing tumour growth, invasion, angiogenesis and chemo-resistance. A clinical trial conducted in parallel with pre-clinical studies showed an anti-IL-6 antibody to have some activity in ovarian cancer patients and in xenograft models, via reduction in pro-inflammatory and angiogenic factors such as TNF-α, IL-8 and VEGF. Anti-IL-6 treatment also showed significant reductions in vascular area with decreased expression of an angiogenic factor Jagged1. The aim o
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Sonnenberg, Sabine. "Tissue specific genetic regulation of Interleukin 6." Thesis, University of Southampton, 2009. https://eprints.soton.ac.uk/72590/.

Texto completo da fonte
Resumo:
Interleukin 6 (IL6) is associated with arterial disease development, progression and surgical outcome. Raised levels of IL6 may play a causal role in disease development or may be the effect of pathology. An IL6 single nucleotide polymorphism (SNP) G- 174C has been identified and reported to associate with IL6 expression. However, conflicting results have emerged and both the relationship between IL6 and vascular disease and the precise effect of SNP G-174C in vivo in humans remains obscure. The aim of this study was to establish the effect of SNP G-174C in humans, in vivo in different tissues
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Livros sobre o assunto "Interleukin-6"

1

Andrzej, Mackiewicz, Koj A, and Sehgal Pravinkumar B, eds. Interleukin-6-type cytokines. New York Academy of Sciences, 1995.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Tamas, Bartfai, and Ottoson David 1918-, eds. Neuro-immunology of fever. Pergamon Press, 1992.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Paulwitz, Adelheid. Diagnostische Wertigkeit von Interleukin-1, Interleukin-6, Interleukin-8, TNF-[alpha] [TNF-alpha] und PMN-Elastase bei akuter Pankreatitis. [s.n.], 1998.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Young, Rosemary Irene. Cytokines and cancer: A focus on Interleukin-6. University of Manchester, 1994.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

B, Sehgal Pravinkumar, Grieninger Gerd, Tosato Giovanna, New York Academy of Sciences., and National Foundation for Cancer Research., eds. Regulation of the acute phase and immune responses: Interleukin-6. New York Academy of Sciences, 1989.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Schwarze, Melinda Margarete K. Mechanisms of prevention of apoptosis in an interleukin-6-dependent myeloma cell line. National Library of Canada, 1995.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Moldoveanu, Andrei Ion. Effects of prolonged endurance exercise on the gene expression and plasma levels of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha. National Library of Canada, 1999.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Rindermann, Dominik. Serumbestimmung von TPS, [beta]2-Mikroglobulin, G-CSF und Interleukin-6 bei Patienten mit metastasierten Nierenzellkarzinom während überwiegend lokaler Immuntherapie mit Interleukin-2. [s.n.], 1998.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Cournoyer, Micheline. Circulating endotoxin, interleukin-6 and tumor necrosis factor alpha in a porcine model of intraabdominal sepsis. National Library of Canada, 1995.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

1946-, Kluger Matthew J., Oppenheim Joost J. 1934-, and Powanda M. C, eds. The Physiologic, metabolic, and immunologic actions of interleukin-1: Proceedings of a symposium held in Ann Arbor, Michigan, June 4-6, 1985. Liss, 1985.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Capítulos de livros sobre o assunto "Interleukin-6"

1

Hirano, T., and T. Kishimoto. "Interleukin-6." In Peptide Growth Factors and Their Receptors I. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-49295-2_14.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Van Snick, J., and R. P. Nordan. "Interleukin 6." In Growth Factors, Differentiation Factors, and Cytokines. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74856-1_12.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Chen, Taosheng. "Interleukin-6." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_3099-3.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Tanaka, Toshio, Masashi Narazaki, and Tadamitsu Kishimoto. "Interleukin-6." In Encyclopedia of Medical Immunology. Springer New York, 2014. http://dx.doi.org/10.1007/978-0-387-84828-0_38.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Gressner, A. M., and O. A. Gressner. "Interleukin-6." In Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_1597-1.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Gressner, A. M., and O. A. Gressner. "Interleukin-6." In Springer Reference Medizin. Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_1597.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Kishimoto, Tadamitsu, and Toshio Tanaka. "Interleukin 6." In Compendium of Inflammatory Diseases. Springer Basel, 2016. http://dx.doi.org/10.1007/978-3-7643-8550-7_179.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Hirano, T., and T. Kishimoto. "Interleukin-6." In Peptide Growth Factors and Their Receptors I. Springer New York, 1991. http://dx.doi.org/10.1007/978-1-4612-3210-0_14.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Chen, Taosheng. "Interleukin-6." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_3099.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Chen, Taosheng. "Interleukin-6." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_3099.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.

Trabalhos de conferências sobre o assunto "Interleukin-6"

1

Morales, Jennifer M., Justin R. Bickford, Sanchao Liu, et al. "Photonic Integrated Circuits with Protein Catalyzed Capture Agents for Biosensing in Complex Media." In Optical Sensors. Optica Publishing Group, 2024. https://doi.org/10.1364/sensors.2024.stu1h.3.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Hu, X., and R. Xing. "Effect of Alternating Electric Field on the Conformation and Function of Interleukin-6." In 2024 IEEE International Conference on Plasma Science (ICOPS). IEEE, 2024. http://dx.doi.org/10.1109/icops58192.2024.10626532.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Jenkins, Brendan J., Louise McLeod, Alistair Miller, et al. "Interleukin-6 Promotes Emphysema By Apoptosis." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5800.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Gopinathan, Ganga, Carla Milagre, Oliver M. T. Pearce, et al. "Abstract 4162: Interleukin–6 stimulates defective angiogenesis." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4162.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Pereira da Silva, F., F. Luís, F. Jesus, et al. "Interleukin-6 in SARS-CoV2 risk stratification." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2216.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Perea, Beatrice, Miriana D’Alessandro, Laura Bergantini, et al. "Interleukin-6 and krebs von den lungen-6 in lymphangioleiomyomatosis patients." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa3949.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Wiegertjes, R., A. van Caam, H. van Beuningen, P. van der Kraan, F. van de Loo, and E. Blaney Davidson. "P078 Transforming growth factor-beta dampens pro-inflammatory interleukin-6 signaling in chondrocytes by decreasing the interleukin-6 receptor." In 39th European Workshop for Rheumatology Research, 28 February–2 March 2019, Lyon, France. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2018-ewrr2019.67.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Tadjibayeva, K., and T. R. Romanovskaya. "REGULATORY ROLE OF INTERLEUKINS-4, 5 AND 6 IN THE DEVELOPMENT OF GLOMERULONEPHRITIS OF VARIOUS ETIOLOGIES." In SAKHAROV READINGS 2022: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2022. http://dx.doi.org/10.46646/sakh-2022-2-24-27.

Texto completo da fonte
Resumo:
The relationship between the concentration of interleukin-4, 5, and 6 with the content of eosinophils and the level of C-reactive protein in patients with chronic glomerulonephritis was established. An increase in eosinophils was found in patients with chronic glomerulonephritis with a predominance of interleukin-4 compared with patients with a predominance of interleukin-5 and 6, which may be an important diagnostic marker of glomerulonephritis.
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Tsang, Andra, and Brian Oliver. "Budesonide reduced stone dust and cigarette smoke-induced interleukin 6 and interleukin 8 production." In ERS Congress 2024 abstracts. European Respiratory Society, 2024. http://dx.doi.org/10.1183/13993003.congress-2024.pa4894.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Kura, Yurie, Marco A. De Velasco, Yasuyuki Kobayashi, et al. "Abstract 1226: Interleukin-6 (IL-6) as a therapeutic target in prostate cancer." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-1226.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.

Relatórios de organizações sobre o assunto "Interleukin-6"

1

Keller, Evan T. Interleukin-6 and Prostate Cancer Progression. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada398242.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Keller, Evan T. Interleukin-6 and Prostate Cancer Progression. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada407280.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Keller, Evan T. Interleukin-6 and Prostate Cancer Progression. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada418080.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Rokita, Hanna, Ruta Neta, and Jean D. Sipe. Increased Fibrinogen Synthesis in Mice During the Acute Phase Response: Co-Operative Interaction of Interleukin 1, Interleukin 6, and Interleukin 1 Receptor Antagonist. Defense Technical Information Center, 1993. http://dx.doi.org/10.21236/ada280464.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Knudsen, Beatrice S. Hepatocyte Growth Factor and Interleukin-6 in Prostate Cancer Bone Metastasis. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada435856.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Knudsen, Beatrice S. Hepatocyte Growth Factor and Interleukin-6 in Prostate Cancer Bone Metastasis. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada428439.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Knudesen, Beatrice S. Hepatocyte Growth Factor and Interleukin-6 in Prostate Cancer Bone Metastasis. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada416620.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Knudsen, Beatrice S. Hepatocyte Growth Factor and Interleukin-6 in Prostate Cancer Bone Metastasis. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada467982.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Huang, Xinyi, Manman Zhang, Jiaojiao Wang, and Fuyong Hu. Association between interleukin-6 levels and stroke:a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.5.0089.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

กาญจนทัต, อภิชาติ. ความเป็นพิษและการเหนี่ยวนำการตายแบบอะโพโทซิสต่อเซลล์มะเร็ง โดยเพปไทด์จากเกสรผึ้งพันธุ์ Apis mellifera. สถาบันวิจัยเทคโนโลยีชีวภาพและวิศวกรรมพันธุศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย, 2018. https://doi.org/10.58837/chula.res.2018.100.

Texto completo da fonte
Resumo:
งานวิจัยนี้เตรียมโปรตีนไฮโดรไลเสตจากเกสรผึ้งพันธุ์ ที่ได้จากปฏิกิริยาย่อยสลายด้วยเอนไซม์ 3 ชนิด ได้แก่ แอลคาเลส ฟลาโวไซม์ และนิวเทรส พบว่าเมื่อใช้นิวเทรสในอัตราส่วนของเอนไซม์ต่อสับสเตรต 1:1 (NH1) โดยปริมาตร จะให้แสดงค่าการยับยั้งการสร้างอนุมูลอิสระด้วยวิธีไนตริกออกไซต์ได้ดีที่สุด คัดแยกเพปไทด์ที่มีขนาดโมเลกุลต่ำกว่า 0.65 กิโลดาลตัน (MW1) มีฤทธิ์ในการขจัดอนุมูลอิสระไนตริกออกไซด์ได้ดีที่สุด จากนั่นได้ทำการตรวจสอบความเป็นพิษของ MW1 ด้วยวิธี MTT และตรวจสอบ ผลการยับยั้งการสร้างไนตริกออกไซด์ในเซลล์แมคโครฟาจ RAW 264.7 ที่ถูกกระตุ้นด้วยไลโปโพลิแซคคาไรด์ พบว่า MW1 ไม่มีความเป็นพิษต่อเซลล์ และมีฤทธิ์ในก
Estilos ABNT, Harvard, Vancouver, APA, etc.
Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!